Sarah Adele

Targeting SUMO to improve the efficiency of differentiation therapies in Acute Myeloid Leukemias

Acute Myeloid Leukemias (AML) are very aggressive hematological malignancies, which treatment is mostly based on intensive chemotherapies. This treatment has not significantly changed in the past 40 years and is characterized by a high relapse rate. Differentiation therapies, in particular those using all-trans retinoic acid (ATRA) are an alternative to chemotherapies. They aim at restoring the differentiation of AML cells … Continue reading Targeting SUMO to improve the efficiency of differentiation therapies in Acute Myeloid Leukemias

Epigenetic Regulation of Imprinted Genes

In their study in Cell reports, Ildem Sanli and her co-workers (Robert Feil lab) explore the epigenetic mechanisms involved in the mono-allelic expression of imprinted genes in mammals. The research focuses on a large chromosomal domain in the mouse. Besides the essential expression of a long non-coding RNA (called Meg3), also the Polycomb Repressive Complex-2 is found to be important … Continue reading Epigenetic Regulation of Imprinted Genes

Marc Sitbon is a MUSE laureate for TheranosMet.

TheranosMet is one of the 8 laureates in Biology & Health of the first call for research projects by MUSE (Montpellier Université d’Excellence). The 3-year MUSE program includes support for a PhD student. TheranosMet focuses on the theranostic use of RBD nanoparticles. RBDs are Receptor-Binding Domains derived from retroviruses that target nutrient transporters. RBDs that bind transporters known to play … Continue reading Marc Sitbon is a MUSE laureate for TheranosMet.